Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Testing Calcium in Urine Can Detect Early Bone Loss

By LabMedica International staff writers
Posted on 07 Jun 2012
Scientists have analyzed calcium isotopes in patients' urine to determine early bone loss. More...


This technique was more sensitive in detecting bone loss than the X-ray method used today, with less risk to patients. Eventually, it could be used in clinical settings, and could be the beginning of additional innovative biosignatures to detect disease.

Scientists at Arizona State University (ASU; Phoenix, AZ, USA) and NASA are developing and applying the technique that originated in the Earth sciences. Using a model developed by ASU Professor, Joseph Skulan, scientists can compare the variously sized isotopes to determine whether patients' bone density is decreasing.

Bone deterioration can strike when a person experiences skeletal unloading--a result of bones not having to carry weight--and that is common in both hospital patients and astronauts. The scientists studied the urine of 12 healthy, but bed-ridden patients, finding that their method could detect bone loss after just a week of bed rest, much faster than the current method of X-ray absorptiometry.

The findings were published in the online Early Edition of the Proceedings of the National Academy of Sciences of the USA (PNAS) the week of May 28, 2012. With proof of concept in hand, the scientists hope to expand the method to detect bone-density changes in cancer patients. "We showed that the concept works as expected in healthy people in a well-defined experiment," said senior author Ariel Anbar. "The next step is to see if it works as expected in patients with bone-altering diseases. That would open the door to clinical applications."

With the new technique, bone loss is detected by carefully analyzing the isotopes of the chemical element calcium that are naturally present in urine. Patients do not need to ingest any artificial tracers and they are not exposed to any radiation, so there is virtually no risk, the authors noted.

The concept extends even beyond bone and calcium, the authors noted. Many diseases cause subtle changes in element isotope abundances, or in the concentrations of elements. These sorts of signatures have not been systematically explored in the development of biosignatures of cancers and other diseases.

Related Links:

Arizona State University
NASA



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.